The Pollack Group Partners with Ascend to help awareness and elevation of Pan-Asian Business Leaders

Published on 23rd January 2025

Written By

Worldcom Partner, The Pollack Group, has announced a partnership with Ascend, the largest Pan-Asian membership organization for business professionals in North America.  Ascend is network of Fortune 500 professionals and executives who volunteer their time to advance the state of AAPI equity at work.

Notably, Ascend also focuses on raising awareness of the unique socio-cultural issues that impact Pan-Asian identity in professional settings. In November 2024, it released its third report on on API mental health and well-being in the workplace and beyond . The series examines most pressing mental health challenge, including work-life balance, invisibility at work, and acculturative stress as immigrants.

“We selected The Pollack Group for its notable experience developing communications and thought leadership platforms for a diverse roster of clients, and we look forward to a fruitful relationship,” said Allie Graham, Head of Marketing at Ascend.

Jackie Liu, senior vice president at The Pollack Group commented that “There are still numerous obstacles and barriers that limit this cohort’s growth potential as business and community leaders. Ascend wants to change that and bring much-needed visibility and awareness to these issues. We are delighted to partner with them.”

To get more details about the partnership and Ascend, you can read the full press release at:  The Pollack Group Partners with Ascend to Bring More Visibility to Underrepresented Research and Initiatives for Pan-Asian Business Leaders.

Related Insights

20 Jul 2026

Why You Need Authenticity in the AI Era

Over the last decade, three has been an increasing pressure to create…

Read more

15 Jul 2026

The Ball Algorithm: How Screens Create the Market’s New Idols

The real paradigm shift in sports lies in how people discovered they…

Read more

11 Jul 2026

The Conversation Pharma Isn't Controlling — and What to Do About It

There is a fundamental mismatch between what pharmaceutical companies say and what…

Read more